Digital Pathology Market is streamlining the diagnostic analysis development with amplified communication between healthcare professionals across the globe

The global market for digital cameras is expected to reach USD 19.77 billion by 2020, according to a new study by Grand View Research, Inc. Growing demand for interchangeable lens cameras with higher selling prices is expected to fuel industry growth over the forecast period. These include digital single lens reflex cameras (DSLR) as well as non-reflex cameras, also referred to as mirror less cameras. Increasing replacement demand coupled with technological enhancements such as Wi-Fi-enabled cameras is expected to favorably impact the market.

The trend of sharing images over the internet and availability of image processing tools has given impetus to the market. Widespread adoption of internet services and surge in social networking activities is expected to further bolster industry outlook. However, proliferation of smartphone globally is a major concern for industry participants, on account of the ready availability and convenience offered by smartphone cameras. The value chain consists of manufacturers of digital cameras and associated parts, as well as retailers or distributors.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/digital-pathology-systems-market

 

Additionally, with the advent of Whole Slide Imaging (WSI), the market is anticipated to witness potential growth opportunities and is currently recognized as one of the foremost promising avenues in the field of diagnostic medicine. Reduced human error and improved accuracy attributable to the automated, slide scanning features, and algorithm-facilitated classification of disease conditions are some of the benefits associated with WSI that is presumed to further accelerate the demand in the future. Additionally, the high healthcare expenditure in the field of cancer diagnostics and the surging demand for personalized medicine has triggered the growth of the digital pathology field. The rising need for automation in image-based analytical tools employed for diagnosis is paving the way for the adoption of digital pathology systems.

High Implementation costs and a stringent regulatory framework pose as major hurdles in the incorporation of digital pathology solutions, particularly in the emerging economies. Currently, the digital pathology system is approved by the U.S. FDA for a limited number of applications, which are research-centric. The untapped diagnostic application areas in the U.S. serve as excellent opportunities for the industry players that are worth capitalizing in the near future. For example, in March 2016, Royal Philips entered into a collaborative agreement with Massachusetts General Hospital, wherein the latter is to serve as a testing center to conduct a multi center device precision study involving the former’s digital pathology WSI, IntelliSite Solution. The study is designed to determine the reproducibility of the IntelliSite pathology solution in primary diagnostic use pertinent to the field of cancer.

The digital pathology market is marked by dynamic activities, such as strategic partnerships which are imperative in widening the consumer base. Recently, in June 2016, the Dutch conglomerate, Royal Philips acquired the Irish, PathXL, one of the largest pathology, image-based analysis firms. This acquisition was carried out in order to develop integrated tools targeting applications in computational pathology, workflow solutions, education, and image analytics. Additionally, this acquisition is aimed at underpinning the gradual transition of medical institutions present across the globe from the traditional systems to digitized pathology systems. The aforementioned acquisition will further enable pathologists to perform high throughput analysis of colossal clinical data images sets that are diverse in nature and facilitate improvements in the diagnosis quality; thereby presenting a potential for the inclusion of new therapies and improvements to enhance patient health outcomes.

In 2014, another prominent market player, Objective Pathology formed a partnership with Microscopes International to introduce their new uSCOPEDigital Microscope to the Canadian market for geographical expansion. The future hence looks promising for the digital pathology industry with the sweeping digitization of tools employed in the diagnostics sector revolutionizing the healthcare industry across the globe.

Read detailed report or request for sample of this research report:
http://www.grandviewresearch.com/industry-analysis/digital-pathology-systems-market/request